Sorafenib in Newly Diagnosed High Grade Glioma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2011 by University Hospital, Geneva.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Andreas F. Hottinger, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT00884416
First received: April 17, 2009
Last updated: August 25, 2011
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)